#1 Clinical Trials Search in Europe

Bisoprolol Fumarate

Bisoprolol Fumarate is a beta-blocker medication that has been the subject of several clinical trials investigating its effectiveness in treating various cardiovascular conditions. This article summarizes key findings from recent studies exploring the use of Bisoprolol Fumarate in conditions such as hypertension, acute coronary syndrome, and heart failure. We’ll examine how this drug performs in different patient populations and its potential benefits and side effects.

Table of Contents

What is Bisoprolol Fumarate?

Bisoprolol Fumarate is a medication that belongs to a class of drugs called beta-blockers. It’s known by various brand names, including Zebeta®, Concor, Cardicor, and Ziac (when combined with hydrochlorothiazide)[1][2][3]. This medication is primarily used to treat high blood pressure (hypertension) and heart conditions.

Conditions Treated with Bisoprolol Fumarate

Bisoprolol Fumarate is used to treat several cardiovascular conditions:

  • Hypertension (High Blood Pressure): It helps lower blood pressure, reducing the risk of heart attacks and strokes[2].
  • Heart Failure: It can improve heart function in patients with chronic heart failure[3].
  • Acute Coronary Syndrome (ACS): This includes conditions like unstable angina and heart attacks. Bisoprolol can help reduce the risk of future heart problems in ACS patients[4].
  • Atrial Fibrillation: It may be used to prevent this irregular heart rhythm after certain heart surgeries[5].

How Bisoprolol Fumarate Works

Bisoprolol Fumarate works by blocking the effects of certain natural chemicals in your body, such as epinephrine (also known as adrenaline). This action:

  • Slows down your heart rate
  • Reduces the force of heart muscle contraction
  • Decreases blood pressure
  • Reduces the workload on the heart, which can be beneficial in heart failure[2][3]

Dosage and Administration

Bisoprolol Fumarate is typically taken orally as a tablet. The dosage can vary depending on the condition being treated and individual patient factors. Here are some general guidelines:

  • For hypertension, a common starting dose is 5 mg once daily, which may be increased to 10 mg if needed[2].
  • For heart failure, doctors often start with a low dose (1.25 mg daily) and gradually increase it over several weeks to reach the target dose (usually 10 mg daily)[3].
  • It’s important to take this medication exactly as prescribed by your doctor. Do not stop taking it suddenly without medical advice, as this can cause serious heart problems[6].

Potential Side Effects

Like all medications, Bisoprolol Fumarate can cause side effects, although not everyone experiences them. Common side effects may include:

  • Fatigue or weakness
  • Dizziness
  • Headache
  • Slow heart rate (bradycardia)
  • Cold hands and feet

If you experience severe side effects or signs of an allergic reaction, seek medical attention immediately[6].

Drug Interactions

Bisoprolol Fumarate can interact with other medications. It’s important to inform your doctor about all medications you’re taking, including over-the-counter drugs and supplements. Some potential interactions include:

  • Other blood pressure medications
  • Certain antidepressants
  • Drugs used to treat diabetes
  • Some medications used for asthma or other breathing problems[7]

Special Considerations

Certain groups of patients may need special consideration when using Bisoprolol Fumarate:

  • Patients with Diabetes: Bisoprolol may mask some symptoms of low blood sugar (hypoglycemia)[8].
  • Patients with Asthma or COPD: While Bisoprolol is considered more “cardioselective” (meaning it primarily affects the heart), it should be used with caution in patients with lung diseases[3].
  • Elderly Patients: They may be more sensitive to the effects of this medication and may require lower doses[4].

Current Research and Developments

Ongoing research is exploring new uses and effects of Bisoprolol Fumarate:

  • Its potential role in preventing atrial fibrillation after heart surgery[5].
  • Its use in early stages of heart muscle disease (cardiomyopathy) in patients with Duchenne muscular dystrophy[9].
  • Studies on how genetic variations might affect how people respond to this medication[4].

Remember, while this information provides a general overview, always consult with your healthcare provider for personalized medical advice tailored to your specific situation.

Aspect Details
Main Uses Hypertension, Heart Failure, Acute Coronary Syndrome
Dosage Range 1.25 mg to 10 mg daily, often titrated gradually
Key Benefits Reduced heart rate, lowered blood pressure, improved heart function
Patient Populations Adults with cardiovascular conditions, including those with diabetes or COPD
Monitoring Parameters Blood pressure, heart rate, ejection fraction, glucose levels
Potential Side Effects Dizziness, fatigue, bradycardia, hypotension
Special Considerations May require dose adjustment in patients with liver or kidney impairment

FAQ

  • What is Bisoprolol Fumarate used for? Bisoprolol Fumarate is primarily used to treat hypertension (high blood pressure), heart failure, and other cardiovascular conditions. It's being studied for its potential benefits in patients with acute coronary syndrome and Duchenne muscular dystrophy-related cardiomyopathy.
  • How does Bisoprolol Fumarate work? Bisoprolol Fumarate is a beta-blocker that works by blocking the effects of adrenaline on the heart. This helps to slow down the heart rate, reduce blood pressure, and decrease the workload on the heart.
  • Are there any side effects associated with Bisoprolol Fumarate? Common side effects may include dizziness, fatigue, and slow heart rate. In some studies, researchers monitored for adverse events such as bradyarrhythmia (abnormally slow heart rate) and hypotension (low blood pressure).
  • Can Bisoprolol Fumarate be used in patients with both heart and lung conditions? Some studies are investigating the use of Bisoprolol Fumarate in patients with both heart failure and chronic obstructive pulmonary disease (COPD). However, careful monitoring is required as beta-blockers can potentially affect lung function.
  • How is the dosage of Bisoprolol Fumarate determined in clinical trials? In many trials, Bisoprolol Fumarate is started at a low dose (e.g., 1.25 mg or 5 mg) and gradually increased over time to reach the target or maximum tolerated dose. The dosage is often adjusted based on the patient's response and any side effects experienced.

Ongoing Clinical Trials on Bisoprolol Fumarate

  • Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • A study testing the reduction of heart failure drug combination in patients with heart failure in remission

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study of drug combination therapy in asymptomatic patients with frequent premature ventricular contractions and normal heart function to prevent left ventricular dysfunction

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study of flecainide alone or with beta-blockers or calcium channel blockers and quinidine for treating ventricular arrhythmias in patients with Andersen-Tawil syndrome and MEPPC

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effects of Bisoprolol and Verapamil in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Optimizing Treatment for Chronic Heart Failure with Reduced Ejection Fraction Using Nebivolol and a Drug Combination

    Recruiting

    1 1 1 1
    Investigated drugs:
    Czechia

  • Study on the Effects of Bisoprolol Fumarate, Hydrochlorothiazide, and Metoprolol in Patients with Idiopathic Ventricular Fibrillation After Cardiac Arrest

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Preventing Heart Disease in Diabetes Patients Using Eprosartan Mesilate and Drug Combination

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Austria Spain

  • Study on the Effects of Carvedilol, Metoprolol Tartrate, and Bisoprolol Fumarate in Patients After a Heart Attack with Normal Heart Pumping Function

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Early Ablation and Use of Amiodarone, Beta-Blockers, or Sotalol for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

Glossary

  • Acute Coronary Syndrome (ACS): A group of conditions that includes unstable angina and heart attacks, characterized by reduced blood flow to the heart.
  • Cardiomyopathy: A group of diseases affecting the heart muscle, often leading to a weakened heart that can't pump blood effectively.
  • Duchenne Muscular Dystrophy (DMD): A genetic disorder characterized by progressive muscle degeneration and weakness, which can also affect the heart.
  • Ejection Fraction: A measurement of how much blood the left ventricle pumps out with each contraction, used to assess heart function.
  • Late Gadolinium Enhancement: A technique used in cardiac MRI to detect scar tissue in the heart muscle.
  • Bioequivalence: The property of two drug products having the same biological effect in the body.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • CYP2D6 and CYP3A4: Enzymes in the liver responsible for metabolizing many drugs, including Bisoprolol Fumarate.
  • NT-proBNP: A hormone released by the heart in response to stress, used as a marker for heart failure.
  • Cardioselective: Refers to drugs that primarily affect the heart rather than other organs or tissues.

References

  1. https://clinicaltrials.gov/study/NCT01741623
  2. https://clinicaltrials.gov/study/NCT01109043
  3. https://clinicaltrials.gov/study/NCT00702156
  4. https://clinicaltrials.gov/study/NCT05536271
  5. https://clinicaltrials.gov/study/NCT03800264
  6. https://clinicaltrials.gov/study/NCT01190436
  7. https://clinicaltrials.gov/study/NCT05536284
  8. https://clinicaltrials.gov/study/NCT04823442
  9. https://clinicaltrials.gov/study/NCT03779646